CLINICAL ROLE -
Increases in Utilization Management of Oncology Medicines by US Payers
Recent increases in the number of therapies indicated for a given oncology subtype has resulted in heightened utilization management stringency.
Read More
Assessing the Value of Pharmaceuticals
There is increased interest in the question of whether pharmacoeconomic studies that measure the value of drug therapies affect clinical decisions and payer policies.